Chronic Disease Management Market Outlook 2024: Exclusive Report By The Business Research Company

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2169

The Business Research Company offers in-depth market insights through Chronic Disease Management Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The chronic disease management market size has grown exponentially in recent years. It will grow from $8.12 billion in 2023 to $9.75 billion in 2024 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to data analytics for population health management, empowerment through patient education, value-based care models, customized treatment plans, focus on preventive healthcare..

The chronic disease management market size is expected to see exponential growth in the next few years. It will grow to $20.38 billion in 2028 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to patient-centric care models, population aging, focus on remote patient monitoring (rpm), increasing prevalence of chronic diseases, global healthcare trends.. Major trends in the forecast period include global health challenges and pandemic response, government initiatives and policy support, consumer health apps and platforms, interoperability and health information exchange, focus on behavioral health, telehealth expansion..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=6984&type=smp

Market Segmentation:
The chronic disease management market covered in this report is segmented -

1) By Service: Consulting Service, Implementation Service, Educational Service
2) By Delivery Mode: On-premise, Cloud-based, Web-based
3) By Disease Type: Cardiovascular Diseases, Diabetes, Cancer, Asthma, Chronic Obstructive Pulmonary Disorders
4) By End User: Providers, Payers

Major Driver - Geriatric Population Growth As A Key Driver Of The Chronic Disease Management Market
The rise in the geriatric population is significantly driving the growth of the chronic disease management market. The geriatric population refers to people above the age of 65 years. Geriatric people have the highest chance of suffering from chronic diseases. Chronic illness often results in an increased need for medical care and supportive long-term care services, increasing the need for the chronic disease management solutions. According to report published in October 2021 by WHO, the proportion of the world's population over 60 years old would nearly double from 12% to 22% between 2015 and 2050. Thus, an increase in the geriatric population will propel the chronic disease management market growth.

Competitive Landscape:
Major companies operating in the chronic disease management market report are Allscripts Healthcare Solutions Inc. (now known as Veradigm Inc. ), ScienceSoft USA Corporation, Siemens Healthcare Private Limited, Infosys Limited, MINES and Associates Inc., Biofourmis Care Solutions Pte. Ltd., i2i Systems Inc., Phytel Inc., Wellcentive Inc., TriZetto Corporation, Mediware Human & Social Services Inc., Pegasystems Inc., ZeOmega Inc., Cigniti Technologies Limited, Health Catalyst, Cedar Gate Technologies, Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management LLC, Casenet LLC, ExlServings Holdings Inc., cliexa Inc., Vivify Health Inc., WellSky, Alkeus Pharmaceuticals, Healthy. io, Immunic Inc., GlaxoSmithKline (GSK), GEOVAX INC., Bluebird Bio, Optum Inc., Omada Health

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/chronic-disease-management-global-market-report

Top Trend - AI-Powered Solutions Transforming Chronic Disease Management
Technological advancement is a key trend gaining popularity in the chronic disease management market. Advanced technologies like artificial intelligence (AI) are being adopted to treat chronic diseases. By utilizing AI, medical personnel can witness advances in early intervention and patient outcomes for patients suffering from heart disease, cancer, and diabetes. For instance, in February 2022, Biofourmis, a Boston-based startup specializing in artificial intelligence-driven virtual care and digital pharmaceuticals, has developed Bioformis Care, a service that provides high-quality remote care to patients suffering from chronic diseases. Biofourmis Care will concentrate on increasing provider adherence to care recommendations and spotting patterns of clinical deterioration to allow for early treatments.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Chronic Disease Management Market Characteristics
3. Chronic Disease Management Market Trends And Strategies
4. Chronic Disease Management Market - Macro Economic Scenario
5. Chronic Disease Management Market Size And Growth
…..
27. Chronic Disease Management Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.